Cartesian Therapeutics, Inc.

RNAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $70.6M $58.7M $32.3M
Accounts Receivable $63.0K $215.0K $824.0K
Inventory — — —
Total Current Assets $98.7M $86.8M $38.9M
Property, Plant & Equipment $2.1M $2.0M $2.0M
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $101.1M $89.3M $42.8M
Liabilities
Accounts Payable $1.6M $3.9M $2.2M
Total Current Liabilities $11.0M $13.7M $7.3M
Long-Term Debt — — —
Total Liabilities $49.3M $34.3M $21.8M
Stockholders' Equity
Retained Earnings $-216.9M $-151.6M $-111.5M
Total Stockholders' Equity $51.8M $55.0M $-116.5M
← Newer Page 2 of 2 Older →